Koji Nishi Selected Research

Koji Nishi Research Topics

Disease

11	Neoplasms (Cancer) 01/2024 - 02/2011
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2016
4	Infections 06/2023 - 11/2017
2	Inborn Urea Cycle Disorders 01/2024 - 02/2023
2	Inflammation (Inflammations) 12/2023 - 07/2007
2	Arthritis (Polyarthritis) 01/2021 - 10/2019
2	Phototoxic Dermatitis (Phototoxicity) 02/2019 - 11/2017
2	Sarcoma 180 02/2011 - 06/2010
1	Cardiotoxicity 01/2024
1	Renal Insufficiency (Renal Failure) 12/2023
1	Hepatitis 12/2023
1	Starvation 01/2023
1	Necrosis 10/2022
1	Mycoses (Diseases, Fungus) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2021
1	Gout 01/2021
1	Hemorrhage 01/2021
1	Infectious Arthritis (Septic Arthritis) 10/2019
1	Leukemia 11/2017
1	Disease Susceptibility (Diathesis) 04/2014
1	Edema (Dropsy) 07/2007

Drug/Important Bio-Agent (IBA)

4	Blood Proteins (Serum Proteins)IBA 12/2023 - 11/2019
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 11/2019
3	4-phenylbutyric acid (Buphenyl)FDA Link 01/2024 - 02/2023
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2023 - 01/2016
3	Human Serum Albumin FDA LinkGeneric 12/2023 - 01/2019
3	Messenger RNA (mRNA)IBA 06/2023 - 10/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 06/2023 - 10/2019
2	4-nitrophenethyl bromide (NPB)IBA 01/2023 - 10/2022
2	CytokinesIBA 01/2021 - 10/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 10/2019
2	Anti-Infective Agents (Microbicides)IBA 02/2019 - 11/2017
2	FluoroquinolonesIBA 02/2019 - 11/2017
1	pirarubicinIBA 01/2024
1	Myristic Acid (Tetradecanoic Acid)IBA 12/2023
1	AlbuminsIBA 12/2023
1	AntioxidantsIBA 12/2023
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2023
1	Concanavalin AIBA 12/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023
1	DisulfidesIBA 12/2023
1	Oleic Acid (Oleate)IBA 12/2023
1	EdaravoneIBA 12/2023
1	Nitric Oxide DonorsIBA 10/2022
1	Adenosine Triphosphate (ATP)IBA 10/2022
1	Nateglinide (Starlix)FDA LinkGeneric 03/2022
1	CaspasesIBA 03/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022
1	AnnexinsIBA 03/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2022
1	EchinocandinsIBA 01/2022
1	Aripiprazole (Abilify)FDA Link 11/2021
1	Signaling Lymphocytic Activation Molecule FamilyIBA 02/2021
1	Basic-Leucine Zipper Transcription FactorsIBA 02/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	nafamostatIBA 01/2021
1	AnticoagulantsIBA 01/2021
1	BenzbromaroneIBA 01/2021
1	LipopeptidesIBA 01/2020
1	Daptomycin FDA Link 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 11/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2019
1	Peptides (Polypeptides)IBA 11/2019
1	InterleukinsIBA 10/2019
1	Interleukin-8 (Interleukin 8)IBA 10/2019
1	Matrix Metalloproteinases (MMPs)IBA 10/2019
1	Glutamine (L-Glutamine)FDA Link 12/2018
1	Acetyl-CoA CarboxylaseIBA 12/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2017
1	lomefloxacin (Maxaquin)FDA Link 11/2017
1	Enoxacin (AT 2266)FDA Link 11/2017
1	Annexin A5IBA 11/2017
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	CholesterolIBA 01/2016
1	LipidsIBA 01/2016
1	5-(tetradecyloxy)-2-furancarboxylic acid (TOFA)IBA 01/2016
1	EnzymesIBA 04/2014
1	CarbonIBA 08/2013
1	FullerenesIBA 08/2013
1	Talaporfin (talaporfin sodium)IBA 02/2011
1	SuspensionsIBA 02/2011
1	13,17- bis(1- carboxyethyl)- 8- (2- (2,4- dichlorophenylhydrazono)ethylidene)- 3- ethenyl- 7- hydroxy- 2,7,12,18- tetramethylchlorinIBA 06/2010
1	CarrageenanIBA 07/2007
1	Dinoprostone (PGE2)FDA Link 07/2007
1	AutacoidsIBA 07/2007
1	Glycoproteins (Glycoprotein)IBA 07/2007
1	Dextrans (Dextran)FDA Link 07/2007
1	KaolinIBA 07/2007

Therapy/Procedure

4	Therapeutics 10/2022 - 08/2013
1	Intravenous Administration 01/2024
1	Drug Therapy (Chemotherapy) 10/2022
1	Renal Dialysis (Hemodialysis) 01/2021